Zhenyu Xiao Net Worth & Insider Trades

Zhenyu Xiao - Director, Diamedica Therapeutics Inc

As of June 26, 2019

What is Zhenyu Xiao's Net Worth?

The current estimated net worth of Diamedica Therapeutics Inc's Director, Zhenyu Xiao, is estimated to be about $2.44M . Zhenyu Xiao owns about 1,007,100 units of Diamedica Therapeutics Inc common stock. In the last year at Diamedica Therapeutics Inc, Zhenyu Xiao has sold an estimated value of $0 worth.

What is Zhenyu Xiao's Past Insider Trading?

Zhenyu Xiao's largest purchase order was 3,250 units , worth over $13K on December 11, 2018. In total, Zhenyu Xiao has made about 2 transactions over a year of their time at Diamedica Therapeutics Inc. Zhenyu Xiao usually trades in June and December, with the busiest year in 2018 and 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Zhenyu Xiao's' Mailing Address?

  • Mailing address is 2 Carlson Parkway Suite 260 Minneapolis MN 55447 MN

Diamedica Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick Pauls 2020 $455,013 - $190,624 $217,716 $14,850 $878,203
Rick Pauls 2019 $420,000 - $890,736 $178,000 $14,650 $733,707
Scott Kellen 2020 $276,075 - $119,140 $79,238 $14,850 $489,303
Scott Kellen 2019 $262,500 - $336,557 $64,800 $13,950 $677,807
Harry Alcorn, Jr., Pharm.D. 2020 $291,413 - $119,140 $83,662 $14,850 $509,065
Harry Alcorn, Jr., Pharm.D. 2019 $273,750 - $421,750 $68,400 $14,400 $778,300
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm

What are Diamedica Therapeutics Inc's Past Insider Trades?

Diamedica Therapeutics Inc's most recent insider trade came on November 16, 2023 by David Wambeke who bought 20,000 units worth $49.2K . In the last 5 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $12.02M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Michael Randall Giuffre, Director,  Richard Pilnik, Director,  and Scott Kellen, CFO and Secretary .

DiaMedica Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...